|
1
|
Chen WQ, Zheng RS, Zeng HM, Zhang SW, Zhao
P and He J: Trend analysis and projection of cancer incidence in
China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi. 34:517–524.
2012.(In Chinese). PubMed/NCBI
|
|
2
|
Zeng HM, Zheng RS, Zhang SW, Zhao P, He J
and Chen WQ: Trend analysis of cancer mortality in China between
1989 and 2008. Zhonghua Zhong Liu Za Zhi. 34:525–531. 2012.(In
Chinese). PubMed/NCBI
|
|
3
|
Siravegna G, Marsoni S, Siena S and
Bardelli A: Integrating liquid biopsies into the management of
cancer. Nat Rev Clin Oncol. 14:531–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mardis ER: Genome sequencing and cancer.
Curr Opinion Genetics Dev. 22:245–250. 2012. View Article : Google Scholar
|
|
5
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mardis ER: New strategies and emerging
technologies for massively parallel sequencing: Applications in
medical research. Genome Med. 1:402009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mardis ER: A decade's perspective on DNA
sequencing technology. Nature. 470:198–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esteban-Jurado C, Vila-Casadesus M, Garre
P, Lozano JJ, Pristoupilova A, Beltran S, Muñoz J, Ocaña T,
Balaguer F, López-Cerón M, et al: Whole-exome sequencing identifies
rare pathogenic variants in new predisposition genes for familial
colorectal cancer. Genet Med. 17:131–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gulbahce N, Magbanua MJM, Chin R, Agarwal
MR, Luo X, Liu J, Hayden DM, Mao Q, Ciotlos S, Li Z, et al:
Quantitative whole genome sequencing of circulating tumor cells
enables personalized combination therapy of metastatic cancer.
Cancer Res. 77:4530–4541. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sabour L, Sabour M and Ghorbian S:
Clinical applications of next-generation sequencing in cancer
diagnosis. Pathol Oncol Res. 23:225–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sunami K, Takahashi H, Tsuchihara K,
Takeda M, Suzuki T, Naito Y, Sakai K, Dosaka-Akita H, Ishioka C,
Kodera Y, et al: Clinical practice guidance for next-generation
sequencing in cancer diagnosis and treatment (Edition 1.0). Cancer
Sci. 109:2980–2985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van Dijk EL, Auger H, Jaszczyszyn Y and
Thermes C: Ten years of next-generation sequencing technology.
Trends Genet. 30:418–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rabbani B, Tekin M and Mahdieh N: The
promise of whole-exome sequencing in medical genetics. J Hum Genet.
59:5–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Swaroop VS, Winawer SJ, Kurtz RC and
Lipkin M: Multiple primary malignant tumors. Gastroenterology.
93:779–783. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gandevia B and Tovell A: Declaration of
Helsinki. Med J Aust. 2:320–321. 1964.PubMed/NCBI
|
|
16
|
Li H and Durbin R: Fast and accurate
long-read alignment with Burrows-Wheeler transform. Bioinformatics.
26:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meyer LR, Zweig AS, Hinrichs AS, Karolchik
D, Kuhn RM, Wong M, Sloan CA, Rosenbloom KR, Roe G, Rhead B, et al:
The UCSC Genome Browser database: Extensions and updates 2013.
Nucleic Acids Res. 41:D64–D69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The Genome Analysis Toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
DePristo MA, Banks E, Poplin R, Garimella
KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
Hanna M, et al: A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nat Genet. 43:491–498.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Van der Auwera GA, Carneiro MO, Hartl C,
Poplin R, Del Angel G, Levy-Moonshine A, Jordan T, Shakir K, Roazen
D, Thibault J, et al: From FastQ data to high confidence variant
calls: the Genome Analysis Toolkit best practices pipeline. Curr
Protoc Bioinformatics. 43:11.10.1–33. 2013.
|
|
21
|
Wang K, Li M and Hakonarson H: ANNOVAR:
Functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
1000 Genomes Project Consortium, ;
Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA,
Hurles ME and McVean GA: A map of human genome variation from
population-scale sequencing. Nature. 467:1061–1073. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sondka Z, Bamford S, Cole CG, Ward SA,
Dunham I and Forbes SA: The COSMIC Cancer Gene Census: Describing
genetic dysfunction across all human cancers. Nat Rev Cancer.
18:696–705. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koboldt DC, Chen K, Wylie T, Larson DE,
McLellan MD, Mardis ER, Weinstock GM, Wilson RK and Ding L:
VarScan: Variant detection in massively parallel sequencing of
individual and pooled samples. Bioinformatics. 25:2283–2285. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amin MB, Edge SB and Greene FL: AJCC
Cancer Staging Manual. 8th. Springer; New York, NY: 2017,
View Article : Google Scholar
|
|
26
|
Gradishar WJ, Anderson BO, Balassanian R,
Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A,
Giordano SH, et al: NCCN Guidelines Insights: Breast cancer,
Version 1.2017. J Natl Compr Canc Netw. 15:433–451. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benson AB III, Venook AP, Bekaii-Saab T,
Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ,
Fuchs CS, et al: Rectal cancer, Version 2.2015. J Natl Compr Canc
Netw. 13:719–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benson AB III, D'Angelica MI, Abbott DE,
Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey
AM, et al: NCCN Guidelines Insights: Hepatobiliary cancers, Version
1.2017. J Natl Compr Canc Netw. 15:563–573. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wierda WG, Zelenetz AD, Gordon LI,
Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P,
Fayad LE, et al: NCCN Guidelines Insights: Chronic Lymphocytic
Leukemia/Small Lymphocytic Lymphoma, Version 1.2017. J Natl Compr
Canc Netw. 15:293–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feldman AT and Wolfe D: Tissue processing
and hematoxylin and eosin staining. Methods Mol Biol. 1180:31–43.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
1000 Genomes Project Consortium, ;
Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker
RE, Kang HM, Marth GT and McVean GA: An integrated map of genetic
variation from 1,092 human genomes. Nature. 491:56–65. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cibulskis K, Lawrence MS, Carter SL,
Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES
and Getz G: Sensitive detection of somatic point mutations in
impure and heterogeneous cancer samples. Nat Biotechnol.
31:213–219. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: Mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39:D945–D950. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ahn SM, Jang SJ, Shim JH, Kim D, Hong SM,
Sung CO, Baek D, Haq F, Ansari AA, Lee SY, et al: Genomic portrait
of resectable hepatocellular carcinomas: Implications of RB1 and
FGF19 aberrations for patient stratification. Hepatology.
60:1972–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reddy A, Zhang J, Davis NS, Moffitt AB,
Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L,
Karjalainen-Lindsberg M L, et al: Genetic and functional drivers of
diffuse large B cell lymphoma. Cell. 171:481–494.e15. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Triepels RH, van den Heuvel LP, Loeffen
JL, Buskens CA, Smeets RJ, Rubio Gozalbo ME, Budde SM, Mariman EC,
Wijburg FA, Barth PG, et al: Leigh syndrome associated with a
mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I.
Ann Neurol. 45:787–790. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lebon S, Minai L, Chretien D, Corcos J,
Serre V, Kadhom N, Steffann J, Pauchard JY, Munnich A, Bonnefont JP
and Rötig A: A novel mutation of the NDUFS7 gene leads to
activation of a cryptic exon and impaired assembly of mitochondrial
complex I in a patient with Leigh syndrome. Mol Genet Metab.
92:104–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lebon S, Rodriguez D, Bridoux D, Zerrad A,
Rotig A, Munnich A, Legrand A and Slama A: A novel mutation in the
human complex I NDUFS7 subunit associated with Leigh syndrome. Mol
Genet Metab. 90:379–382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen H, Sun X, Ge W, Qian Y, Bai R and
Zheng S: A seven-gene signature predicts overall survival of
patients with colorectal cancer. Oncotarget. 8:95054–95065.
2016.PubMed/NCBI
|
|
41
|
Duan M, Hao J, Cui S, Worthley DL, Zhang
S, Wang Z, Shi J, Liu L, Wang X, Ke A, et al: Diverse modes of
clonal evolution in HBV-related hepatocellular carcinoma revealed
by single-cell genome sequencing. Cell Res. 28:359–373. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Varrault A, Ciani E, Apiou F, Bilanges B,
Hoffmann A, Pantaloni C, Bockaert J, Spengler D and Journot L: hZAC
encodes a zinc finger protein with antiproliferative properties and
maps to a chromosomal region frequently lost in cancer. Proc Natl
Acad Sci USA. 95:8835–8840. 1998. View Article : Google Scholar : PubMed/NCBI
|
